Axsome Therapeutics Inc Working Capital to Net Assets Ratio
Axsome Therapeutics Inc working capital to net assets ratio. Axsome Therapeutics Inc (AXSM) has a Working Capital to Net Assets ratio of 235.4% as of June 2026. Working capital of $196.12 Million (current assets of $656.57 Million minus current liabilities of $460.45 Million) is measured against net assets of $83.30 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Axsome Therapeutics Inc (2013–2025)
Working capital to net assets ratio of Axsome Therapeutics Inc from 2013 to 2025. This chart shows how Axsome Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 235.4%, reflecting working capital of $196.12 Million against net assets of $83.30 Million USD. See Axsome Therapeutics Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Axsome Therapeutics Inc Working Capital to Net Assets Ratio by Year (2013–2025)
Axsome Therapeutics Inc working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Axsome Therapeutics Inc from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Axsome Therapeutics Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 238.0% | $210.15 Million | $88.30 Million | $588.99 Million | $378.84 Million | ▼ -209.2 pp |
| 2024 | 447.2% | $254.96 Million | $57.02 Million | $485.06 Million | $230.10 Million | ▲ +255.8 pp |
| 2023 | 191.3% | $365.41 Million | $190.98 Million | $504.26 Million | $138.85 Million | ▲ +55.3 pp |
| 2022 | 136.1% | $149.08 Million | $109.56 Million | $245.64 Million | $96.56 Million | ▼ -269.9 pp |
| 2021 | 406.0% | $63.45 Million | $15.63 Million | $86.52 Million | $23.07 Million | ▲ +264.8 pp |
| 2020 | 141.1% | $160.59 Million | $113.79 Million | $184.02 Million | $23.44 Million | ▲ +31.5 pp |
| 2019 | 109.6% | $195.88 Million | $178.72 Million | $220.38 Million | $24.49 Million | ▼ -358.8 pp |
| 2018 | 468.4% | $4.39 Million | $937.92K | $15.22 Million | $10.82 Million | ▲ +330.1 pp |
| 2017 | 138.3% | $23.12 Million | $16.72 Million | $35.30 Million | $12.18 Million | ▼ -4.6 pp |
| 2016 | 142.9% | $30.83 Million | $21.57 Million | $38.00 Million | $7.17 Million | ▲ +43.0 pp |
| 2015 | 99.9% | $46.40 Million | $46.44 Million | $49.03 Million | $2.63 Million | ▲ +155.2 pp |
| 2014 | -55.3% | $1.77 Million | $-3.20 Million | $2.74 Million | $972.62K | ▼ -155.3 pp |
| 2013 | 100.0% | $-2.03 Million | $-2.03 Million | $2.10 Million | $4.13 Million | — |